Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2012
10/25/2012US20120270896 Antineoplastic Combinations Containing HKI-272 and Vinorelbine
10/25/2012US20120270892 Aminopyrimidine Kinase Inhibitors
10/25/2012US20120270889 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
10/25/2012US20120270886 Inhibitors of iap
10/25/2012US20120270882 Fluorinated derivates of 3-hydroxypyridin-4-ones
10/25/2012US20120270881 Conformationally constrained, fully synthetic macrocyclic compounds
10/25/2012US20120270880 Pyrrolo [2,3-d] pyrazin-7-ylpyrimidine compounds
10/25/2012US20120270877 IRE-1alpha INHIBITORS
10/25/2012US20120270874 Biaryl Compositions and Methods for Modulating a Kinase Cascade
10/25/2012US20120270872 Crystalline Forms of N-[3-fluoro-4-(oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
10/25/2012US20120270871 Pyrrolopyridinylpyrimidin-2-ylamine derivatives
10/25/2012US20120270868 Rho kinase inhibitors
10/25/2012US20120270867 Novel (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
10/25/2012US20120270863 Fused ring analogues of anti-fibrotic agents
10/25/2012US20120270859 Indoline derivatives and their use in treating disease-states such as cancer
10/25/2012US20120270858 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
10/25/2012US20120270857 5-ht3 receptor modulators, methods of making, and use thereof
10/25/2012US20120270852 Phenyl or pyridinyl-ethynyl derivatives
10/25/2012US20120270850 Metal delivery agents and therapeutic uses of the same
10/25/2012US20120270845 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases
10/25/2012US20120270841 Diazonamide Analogs
10/25/2012US20120270840 Proteasome inhibitors and processes for their preparation, purification and use
10/25/2012US20120270839 Compositions and methods for cancer treatment
10/25/2012US20120270838 Spiroimidazolone derivative
10/25/2012US20120270831 Method for treating hematopoietic neoplasms
10/25/2012US20120270826 Adult stem cells, molecular signatures, and applications in the evaluation, diagnosis, and therapy of mammalian conditions
10/25/2012US20120270823 Aureolic acid derivatives, the method for preparation thereof and the uses thereof
10/25/2012US20120270818 Hdac 6 inhibitor-based methods for treating cancer
10/25/2012US20120270817 6-Substituted Estradiol Derivatives and Methods of Use
10/25/2012US20120270812 Compositions, methods, and kits for determining an alkyl transferase
10/25/2012US20120270809 Human transmembrane proteins
10/25/2012US20120270803 Mitotic Kinesin Inhibitors and Methods of Use Thereof
10/25/2012US20120270802 Binding molecules for the treatment of myeloid cell malignancies
10/25/2012US20120270801 Her3 binding polypeptides
10/25/2012US20120270800 Bifunctional stapled polypeptides and uses thereof
10/25/2012US20120270799 METHOD OF IDENTIFYING A CANDIDATE COMPOUND WHICH MAY INHIBIT a9-nAchR OVEREXPRESSION OR ESTROGEN RECEPTOR-DEPENDENT TRANSCRIPTION IN NICOTINE-DERIVED-COMPOUND-INDUCED BREAST CANCER CELLS
10/25/2012US20120270798 Compositions and Methods for Preventing or Treating Cancer
10/25/2012US20120270797 Engineered proteins including mutant fibronectin domains
10/25/2012US20120270787 Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof
10/25/2012US20120270781 Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D, and Method of Treating Melanomas
10/25/2012US20120270770 Anti-angiogenic peptides and their uses
10/25/2012US20120270769 Methods of using macrocyclic inhibitors of serine protease enzymes
10/25/2012US20120270768 Tumor Activated Prodrugs
10/25/2012US20120270767 Tumor Activated Prodrugs
10/25/2012US20120270736 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
10/25/2012US20120269903 Novel mannopyranoside derivatives with anticancer activity
10/25/2012US20120269902 Thiazole Compounds, and Compositions and Methods Using Same
10/25/2012US20120269901 Methods and Compounds Useful to Induce Apoptosis in Cancer Cells
10/25/2012US20120269883 MicroRNA-140-5P as a Tumor Suppressor and Sensitizing Agent for Chemotherapy
10/25/2012US20120269880 Purified amniotic membrane compositions and methods of use
10/25/2012US20120269869 Colon vitamin
10/25/2012US20120269867 Methods of treating central nervous system tumors
10/25/2012US20120269864 Arginine Derivatives with NP-I Antagonistic Activity
10/25/2012US20120269861 Treatment of breast cancer with iodonitrobenzamides in combination with anti-tumor agents
10/25/2012US20120269860 Method for Proliferation of Antigen-Specific T Cells
10/25/2012US20120269859 Multimer of extracellular domain of cell surface functional molecule
10/25/2012US20120269858 Polypeptides
10/25/2012US20120269857 Analogs of alpha galactosylceramide and uses thereof
10/25/2012US20120269844 Vaccines for the treatment of neoplasias from viral capsids of birnavirus containing antigens of the human papillomavirus
10/25/2012US20120269838 Carrier conjugates of il-23-peptides and their induced antibodies
10/25/2012US20120269835 Process for the production of immunogenic compositions
10/25/2012US20120269834 Immunoglobulin cleavage fragment vaccine compositions
10/25/2012US20120269831 Substituted pyrido[2,3-d]pyrimidin-7(8h)-ones and therapeutic uses thereof
10/25/2012US20120269827 Compositions and Methods for Treatment of Ovarian, Peritoneal, and Fallopian Tube Cancer
10/25/2012US20120269825 Methods of modulating the ox40 receptor to treat cancer
10/25/2012US20120269820 Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof
10/25/2012US20120269818 Methods for treating infection by hpv
10/25/2012US20120269812 Monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies
10/25/2012US20120269811 Humanized fc gamma riib-specific antibodies and methods of use thereof
10/25/2012US20120269808 Methods and compositions for modulating tweak and fn14 activity
10/25/2012US20120269804 Substituted benzosulphonamides
10/25/2012US20120269803 Substituted benzosulphonamides
10/25/2012US20120269802 Treatment And Prognosis With Thalidomide In Multiple Myeloma Based on Karyotyping And Gene Expression Profiling
10/25/2012US20120269801 Methods and compositions for the treatment of proliferative and pathogenic diseases
10/25/2012US20120269800 Anti-neoplastic compositions comprising extracts of black cohosh
10/25/2012US20120269799 Diagnostic and treatment methods using a ligand library
10/25/2012US20120269790 Use of plant extracts as prebiotics, compositions and foods containing such extract
10/25/2012US20120269773 Recombinant adenoviruses encoding the specific iodine transporter (nis)
10/25/2012US20120269726 Heterodimers of Glutamic Acid
10/25/2012US20120269725 Targeted radiolabeled compounds and their use for the treatment and diagnosis of cancer
10/25/2012US20120269723 Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent
10/25/2012DE102011018472A1 Disappearance of tumors in 6 weeks, using faba bean meal, salt, water, bag made of terry cloth, film and plaster
10/24/2012EP2514768A1 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant
10/24/2012EP2514766A2 Antibodies, methods and kits for diagnosing and treating melanoma
10/24/2012EP2514765A1 Gpr177 as target and marker in tumors
10/24/2012EP2514764A2 Antibody molecules which bind IL-17A and IL-17F
10/24/2012EP2514761A1 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
10/24/2012EP2514752A1 Epothilone compounds, preparation method and use thereof
10/24/2012EP2514751A1 Azaindazoles useful as inhibitor of kinases
10/24/2012EP2514742A2 Orally bioavailable cafeic acid related anticancer drugs
10/24/2012EP2514483A1 Adjuvant immunotherapy for the preventive, curative or palliative treatment of chronic systemic diseases such as cancer, of clinical manifestations associated with these diseases, such as cachexia, and remedying adverse effects of drugs and treatments, such as immunodepression, neutropenia and lymphocytopenia, comprising the association or combination of a specially selected biological response modifier and other antineoplastic compounds and/or other treatments
10/24/2012EP2514441A1 Passive solid tumor targeting anticancer prodrug and preparation method thereof
10/24/2012EP2514425A1 Composition containing protopanaxatriol and protopanaxadiol
10/24/2012EP2513225A1 Local delivery of drugs from self assembled coatings
10/24/2012EP2513137A2 Saposin-a derived peptides and uses thereof
10/24/2012EP2513121A1 Prostate specific membrane antigen inhibitors
10/24/2012EP2513111A1 Mk2 inhibitors
10/24/2012EP2513110A1 1, 7 - diazacarbazoles and their use in the treatment of cancer
10/24/2012EP2513109A1 Heterocyclic compounds and their uses
10/24/2012EP2513098A1 Aminopyrimidines as syk inhibitors
1 ... 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 ... 2211